Back to results
US 2025/0367201 A1Published application
Combination therapy for treating abnormal cell growth
AssigneeVerastem, Inc.
InventorsSILVIA COMA, JONATHAN A. PACHTER
Life of this patent
Estimating the term…
Abstract
The present invention relates, in part, to methods, compounds, and compositions of a KRAS G12D inhibitor in combination with a dual RAF/MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
Claims50
A method of treating a cancer in a subject in need thereof, the method comprising administering to the subject an effective amount of a dual RAF/MEK inhibitor and an effective amount of a KRAS G12D inhibitor.
Dependencies are inferred from the claim text.